Fosun Pharma, CanSino take different paths as Covid lift fade
The pair of companies that got strong shots from different Covid vaccines are telling different stories in their latest quarterly results as the pandemic draws down Key Takeaways: Fosun Pharma’s…
One-Trick Pony Boan Biotech Files for Hong Kong IPO Into Tough Market
The biotech company is awaiting approval on a second drug to drive up revenue as it firms its foothold in a competitive landscape Key Takeaways: Boan Biotechnology sells only one…
Recent Articles
RELATED ARTICLES
-
Health Guard plans dual listing to fund HPV vaccine fight
-
Fosun Tourism at crossroads as parent shops its two major assets
1992.HK 0656.HK
-
Fosun International on cusp of new ‘asset-light’ era with latest sale
0656.HK
-
Everest Medicines eyes mRNA tumor vaccines as drug valuations rebound
1952.HK
-
Fosun Tourism embarks on new journey with departure of big-name director
1992.HK
-
Shunned by investors, Henlius hangs up on its Hong Kong listing
2696.HK
